PriceTargets.com logo

Inovalon - INOV Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$29.27 As of 12/2/2024 01:00 AM ET
▲ +0.05 (0.17%)
Get New Inovalon Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for INOV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for INOV

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Inovalon in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $29.27.

This chart shows the closing price for INOV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Inovalon. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/6/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/4/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/3/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/26/2021Piper SandlerUpgradeUnderweight ➝ Neutral
8/19/2021BTIG ResearchDowngradeBuy ➝ Neutral
8/19/2021Leerink PartnersDowngradeOutperform ➝ Market Perform$45.00 ➝ $41.00
8/19/2021Robert W. BairdDowngradeOutperform ➝ Neutral
7/29/2021Piper SandlerBoost TargetUnderweight$22.00 ➝ $23.00
7/29/2021KeyCorpBoost TargetOverweight$35.00 ➝ $40.00
7/28/2021Leerink PartnersBoost TargetOutperform$35.00 ➝ $45.00
5/27/2021Robert W. BairdInitiated CoverageOutperform$27.00
5/19/2021BTIG ResearchBoost TargetPositive ➝ Buy$35.00 ➝ $40.00
4/29/2021KeyCorpBoost TargetOverweight$29.00 ➝ $35.00
4/29/2021Leerink PartnersBoost TargetOutperform$31.00 ➝ $35.00
2/4/2021Morgan StanleyBoost TargetEqual Weight$23.00 ➝ $25.00
2/4/2021Leerink PartnersBoost TargetOutperform$27.00 ➝ $31.00
2/4/2021Piper SandlerBoost TargetCautious ➝ Underweight$14.00 ➝ $22.00
1/12/2021BTIG ResearchBoost TargetBuy$25.00 ➝ $30.00
1/6/2021BTIG ResearchInitiated CoverageBuy$25.00
11/30/2020Morgan StanleyLower TargetEqual Weight$25.00 ➝ $23.00
10/29/2020Piper SandlerBoost TargetUnderweight$13.00 ➝ $15.00
9/3/2020KeyCorpBoost TargetOverweight$24.00 ➝ $29.00
8/11/2020CitigroupBoost TargetNeutral$24.00 ➝ $26.00
7/31/2020Morgan StanleyBoost TargetEqual Weight$18.00 ➝ $25.00
7/30/2020Leerink PartnersBoost TargetOutperform$21.00 ➝ $25.00
7/30/2020KeyCorpBoost TargetOverweight$22.00 ➝ $24.00
7/14/2020CitigroupInitiated CoverageNeutral$20.00
6/11/2020GuggenheimBoost TargetBuy$22.00 ➝ $26.00
5/21/2020GuggenheimInitiated CoverageBuy$22.00
4/30/2020Wells Fargo & CompanyLower TargetEqual Weight$22.00 ➝ $20.00
4/30/2020KeyCorpBoost TargetOverweight$20.00 ➝ $22.00
4/13/2020Leerink PartnersInitiated CoverageOutperform$21.00
3/26/2020SunTrust BanksLower TargetBuy$26.00 ➝ $23.00
3/26/2020KeyCorpReiterated RatingOverweight$25.00 ➝ $20.00
2/20/2020Piper SandlerBoost Target$12.00 ➝ $14.00
2/20/2020SunTrust BanksBoost TargetBuy$25.00 ➝ $26.00
2/20/2020KeyCorpBoost TargetOverweight$22.00 ➝ $25.00
1/8/2020Wells Fargo & CompanyBoost TargetEqual Weight$17.50 ➝ $20.00
(Data available from 12/3/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/7/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/6/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/6/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/5/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/4/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/4/2024
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/3/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/3/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Inovalon logo
Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.
Read More

Today's Range

Now: $29.27
Low: $29.16
High: $29.31

50 Day Range

MA: $40.92
Low: $40.66
High: $41.06

52 Week Range

Now: $29.27
Low: $17.56
High: $41.06

Volume

9,678 shs

Average Volume

720,587 shs

Market Capitalization

$4.54 billion

P/E Ratio

86.09

Dividend Yield

N/A

Beta

0.53

Frequently Asked Questions

What sell-side analysts currently cover shares of Inovalon?

The following equities research analysts have issued stock ratings on Inovalon in the last year: StockNews.com.
View the latest analyst ratings for INOV.

What is the current price target for Inovalon?

0 Wall Street analysts have set twelve-month price targets for Inovalon in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Inovalon in the next year.
View the latest price targets for INOV.

What is the current consensus analyst rating for Inovalon?

Inovalon currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for INOV.

What other companies compete with Inovalon?

Other companies that are similar to Inovalon include Globant, Bilibili, Pegasystems, QXO and Clarivate. Learn More about companies similar to Inovalon.

How do I contact Inovalon's investor relations team?

Inovalon's physical mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company's listed phone number is (301) 809-4000 and its investor relations email address is [email protected]. The official website for Inovalon is www.inovalon.com. Learn More about contacing Inovalon investor relations.